ArticleBrain : a journal of neurology2026
The Wnt5a-PKCδ-GluA1 axis controls synapse-specific plasticity in HIV-1 gp120-induced pain pathogenesis.
Article in Brain : a journal of neurology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Imbalance of excitatory and inhibitory neuronal activity (E/I imbalance) plays a critical role in pain pathogenesis. Recent studies have identified a novel form of E/I imbalance in the spinal dorsal horn of animal models of HIV-associated pain, manifesting as increased spontaneous excitatory postsynaptic current (sEPSC) frequency in excitatory neurons alongside decreased sEPSC frequency in inhibitory neurons and hence termed neural circuitry polarization. However, how the opposite forms of synaptic plasticity in neural circuitry polarization are coordinated in the pain neural circuit is unclear. Here, we show that in the spinal dorsal horn of a mouse model of HIV-associated pain, potentiation of excitatory synapses on excitatory neurons (ESE) and depression of excitatory synapses on inhibitory neurons (ESI) employ distinct mechanisms to support their expression. We found the increase of sEPSC frequency in excitatory neurons induced by HIV-1 gp120 was mediated by a postsynaptic mechanism, whereas decrease of sEPSC frequency in inhibitory neurons was mediated by a presynaptic mechanism. Our studies showed that pharmacological inhibition of calcium-permeable AMPA (CP-AMPA) receptors selectively attenuated potentiation of ESE without significantly affecting ESI depression. We also observed that GluA1 was upregulated in excitatory but not inhibitory neurons, indicating selective CP-AMPA receptor formation in excitatory neurons. Furthermore, we identified a new pain-related signalling pathway in ESE: Wnt5a-PKCδ-GluA1. We elucidated that the GluA1 upregulation and ESE potentiation were controlled by neuronal Wnt5a signalling via protein kinase C delta (PKCδ). Our findings reveal that ESE and ESI in the spinal dorsal horn of HIV pain models use distinct synaptic and molecular mechanisms to support their expression in neural circuitry polarization, demonstrating specialized regulatory pathways for the plasticity of excitatory synapses targeting different neuron types during the pain pathogenesis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.